Dysregulated immune responses in COVID-19 patients correlating with disease severity and invasive oxygen requirements
Authors:
- Mirliana Ramirez-PereiraMRMirliana Ramirez-Pereira
Preprint
Abstract
The prognosis of severe COVID-19 patients has motivated research communities to uncover mechanisms of SARS-CoV-2 pathogenesis also on a regional level. In this work, we aimed to understand the immunological dynamics of severe COVID-19 patients with different degrees of illness, and upon long-term recovery. We analyzed immune cellular subsets and SARS-CoV-2-specific antibody isotypes of 66 COVID-19 patients admitted to the Hospital Clínico Universidad de Chile, which were categorized according to the WHO ten-point clinical progression score. These included 29 moderate patients (score 4-5) and 37 severe patients under either high flow oxygen nasal cannula (18 patients, score 6), or invasive mechanical ventilation (19 patients, score 7-9), plus 28 convalescent patients and 28 healthy controls. Furthermore, six severe patients that recovered from the disease were longitudinally followed over 300 days. Our data indicate that severe COVID-19 patients display increased frequencies of plasmablasts, activated T cells and SARS-CoV-2-specific antibodies compared to moderate and convalescent patients. Remarkably, within the severe COVID-19 group, patients rapidly progressing into invasive mechanical ventilation show higher frequencies of plasmablasts, monocytes, eosinophils, Th1 cells and SARS-CoV-2-specific IgG than patients under high flow oxygen nasal cannula. These findings demonstrate that severe COVID-19 patients progressing into invasive mechanical ventilation show a distinctive type of immunity. In addition, patients that recover from severe COVID-19 begin to regain normal proportions of immune cells 100 days after hospital discharge and maintain high levels of SARS-CoV-2-specific IgG throughout the study, which is an indicative sign of immunological memory. Thus, this work can provide a useful benchmark for improvement of disease outcomes.Keywords
All Related Versions
- Published version: Frontiers in Immunology, 12, 769059.
This publication has 39 references indexed in Scilit:
- COVID-19 and the human innate immune systemCell, 2021
- Adaptive immunity to SARS-CoV-2 and COVID-19Cell, 2021
- Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, ItalyJAMA Internal Medicine, 2020
- Emerging Pandemic Diseases: How We Got to COVID-19Cell, 2020
- Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentCell, 2020
- Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Factors That Regulate the Generation of Antibody-Secreting Plasma Cells2016